Telford-based Solesis, a designer, developer and manufacturer of textile- and polymer-based healthcare solutions for the medical device and biopharmaceutical industries, recently announced it will be building a manufacturing facility in Costa Rica.
The location will be dedicated to producing implantable textile components, polymer-based devices and components, and single-use technologies, and is expected to begin operations in the spring of 2025. It will include cleanrooms.
“Expanding into Costa Rica will significantly increase our global capacity, enabling us to rapidly expand and optimize our resources to provide our customers with comprehensive business continuity avenues that mitigate supply chain risks,” Jeff Robertson, Solesis chief operating officer, said. “Costa Rica is a global medical device hub and a prime location for expanding the production of our critical healthcare solutions. In fact, many of our customers already have established manufacturing operations in this region and we look forward to continued collaboration with them.”
The facility is located in the Greenpark Free Trade Zone, the first industrial park and Free Trade Zone in Latin America that is environmentally sustainable.
Solesis employs more than 450 people in Pennsylvania and North Carolina and operates five production facilities. It operates under its subsidiaries Secant Group, Polyzen, Charter Medical and SanaVita Medical.